Last updated: April 4, 2017
Sponsor: Human Stem Cell Institute, Russia
Overall Status: Completed
Phase
N/A
Condition
Diabetes And Hypertension
Treatment
N/AClinical Study ID
NCT02538705
NeoFoot Pilot Study
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
obtained voluntary informed consent for participation in the clinical study
presence of diabetic foot syndrome
presence at least one active ulcer at baseline
Exclusion
Exclusion Criteria:
Any disease that can, in the opinion of the treating physician, affect the outcome ofthe study
Patients with addictive disorders or substance abuse
Pregnancy or nursing
All other exclusion criteria listed in the summary of product characteristics (SmPC)
Study Design
Total Participants: 35
Study Start date:
August 01, 2015
Estimated Completion Date:
January 01, 2016
Study Description
Connect with a study center
Human Stem Cell Institute
Moscow,
Russian FederationSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.